Skip to main content
. 2016 May 20;16:98. doi: 10.1186/s12872-016-0267-6

Table 1.

Baseline characteristics of acute heart failure patients with and without acute coronary syndrome

Overall
n = 2609
ACS-AHF
n = 725 (27.79 %)
NACS-ACS
n = 1884 (72.21 %)
P value
Demographics
 Age, years; mean ± SD 61.34 ± 15 62.74 ± 13.1 60.80 ± 15.6 0.003
 Male, n (%) 1717 (65.81) 535 (73.79) 1182 (62.74) <0.001
 Saudi nationality, n (%) 2230 (85.47) 546 (75.31) 1684 (89.38) <0.001
Medical history
 Heart failure, n (%) 1670 (64.2) 315 (43.5) 1355 (72.2) <0.001
 Ischemic heart disease, n (%) 1376 (53.3) 433 (60.1) 943 (50.6) <0.001
 PCI, n (%) 340 (13.1) 109 (15.0) 231 (12.3) 0.064
 CABG, n (%) 261 (10.0) 52 (7.2) 209 (11.1) 0.003
 Rheumatic heart disease, n (%) 183 (7.1) 4 (0.5) 179 (9.6) <0.001
 Atrial fibrillation, n (%) 408 (15.7) 37 (5.1) 371 (19.8) <0.001
 ICD, n (%) 229 (8.8) 31 (4.3) 198 (10.5) <0.001
 CRT, n (%) 85 (3.3) 7 (0.8) 78 (4.1) <0.001
 Stroke/TIA, n (%) 252 (9.7) 67 (9.2) 185 (9.8) 0.637
 PAD, n (%) 99 (3.8) 37 (5.1) 62 (3.3) 0.034
 Anemia, n (%) 1166 (44.9) 301 (41.7) 865 (46.2) 0.043
 Chronic lung disease, n (%) 185 (7.1) 37 (5.1) 148 (7.9) 0.013
 Chronic kidney disease, n (%) 771 (29.7) 163 (22.5) 608 (32.4) <0.001
 Liver disease, n (%) 91 (3.5) 9 (1.2) 82 (4.4) <0.001
 Thyroid disorder, n (%) 172 (6.8) 28 (4.0) 144 (7.9) <0.001
Risk factors for atherosclerosis
 Smoking, n (%) 467 (17.9) 182 (25.1) 285 (15.1) <0.001
 Hypertension, n (%) 1831 (70.6) 506 (70.8) 1325 (70.5) 0.914
 Dyslipidemia, n (%) 894 (36.4) 289 (42.7) 605 (34.0) <0.001
 Diabetes mellitus, n (%) 1668 (64.1) 518 (72.0) 1150 (61.1) <0.001
Clinical parameters on presentation
 Acute de novo HF, n (%) 939 (36.0) 410 (56.5) 529 (28.1) <0.001
 Acute on chronic HF, n (%) 1670 (64.0) 315 (43.4) 1355 (71.9)
 BMI, kg/m2; mean ± SD* 29.16 ± 6.7 28.12 ± 5.4 29.55 ± 7.1 <0.001
 SBP, mean ± SD 128.7 ± 31.3 126.6 ± 29.8 129.5 ± 31.9 0.038
 DBP, mean ± SD 74.10 ± 17.9 73.67 ± 17.1 74.26 ± 18.2 0.454
 HR, mean ± SD 88.8 ± 21.0 89.7 ± 19.1 88.5 ± 21.7 0.185
Investigations
 Electrocardiography
  Atrial fibrillation/flutter, n (%) 449 (17.2) 52 (7.2) 397 (21.1) <0.001
  QRS ≥120 msec, n (%) 389 (14.9) 68 (9.4) 321 (17.1) <0.001
  LBBB, n (%) 305 (11.7) 62 (8.5) 243 (12.9) 0.002
 Biochemical parameters
  Sodium, mmol/L; mean ± SD 135.1 ± 5.3 135.0 ± 5.4 135.2 ± 5.3 0.322
  Potassium, mmol/L; mean ± SD 4.3 ± 0.7 4.2 ± 0.7 4.3 ± 0.7 0.644
  Urea, μmol/L; mean ± SD 11.87 ± 9.1 11.11 ± 8.4 12.16 ± 9.3 0.008
  Creatinine, μmol/L; median (IQR] 109.0 (70.0) 109.0 (62.0) 109.0 (73.0) 0.923
  eGFR, ml/min/1.73 m2; median (IQR) 57.28 (43.5) 56.32 (41.9) 57.82 (44.1) 0.444
  Hemoglobin, g/dL; mean ± SD 12.43 ± 2.2 12.76 ± 2.3 12.31 ± 2.2 <0.001
  RBS, mmol/L; mean ± SD 10.01 ± 5.7 11.43 ± 6.2 9.45 ± 5.4 <0.001
  NT-Pro-BNP, pmol/L; n (%) 435 (16.7) 101 (13.9) 334 (17.7) 0.019
  NT-Pro-BNP, pmol/L; median (IQR) 675.0 (668) 999.0 (1679) 631.5 (684) <0.001
  Positive troponin, n (%) 867 (37.4) 693 (98.6) 174 (10.8) <0.001
 Echocardiography
  Left ventricular EF >55 %, n (%) 341 (13.7) 50 (7.2) 291 (16.2) <0.001
  Left ventricular EF 40–54.9 % 334 (13.4) 113 (16.2) 221 (12.3) <0.001
  Left ventricular EF 30–9.9 % 632 (25.3) 258 (37.1) 374 (20.8) <0.001
  Left ventricular EF <30 % 1187 (47.6) 275 (39.5) 912 (50.7) <0.001

Abbreviations: ACS-AHF acute coronary syndrome with acute heart failure, ACS-NASC no acute coronary syndrome with acute heart failure, BMI body mass index, BNP brain natriuretic peptide, CABG coronary artery bypass surgery, CRT cardiac resynchronization therapy, DBP diastolic blood pressure, EF ejection fraction, eGFR estimated glomerular filtration rate, HR heart rate, ICD internal cardiac defibrillator, LBBB left bundle branch block, PAD peripheral artery disease, PCI percutaneous coronary intervention, RBS random blood sugar, SD standard deviation, SBP systolic blood pressure, TIA transient ischemic attack